Početna › Parkinsonova bolest › Kansas
Kliničke studije za Parkinsonova bolest u državi Kansas
10 studija za Parkinsonova bolest traži sudionike na lokacijama u državi Kansas.
Gradovi u državi Kansas
Službeni tekst studije (engleski)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 2
Od 40 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-029, Kansas City
U tijeku regrutacijaFaza 2/3
Od 40 do 80 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06976268A Study of Buntanetap in Participants With PD
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D, Kansas City
U tijeku regrutacijaFaza 2/3
Od 40 do 85 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #041, Overland Park
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- The University of Kansas (KU) (Site #216), Kansas City
U tijeku regrutacijaFaza 2
Od 30 do 80 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of Kansas, Lawrence
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 3
Od 50 do 85 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 3
Od 45 do 75 godina · Oba spola · Ažurirano 4. kol 2026. · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 30 godina i više · Oba spola · Ažurirano 27. srp 2026. · NCT04477785A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2025. · NCT06765668Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.